NCT01193296 - Glycemic Holter Study (Continuous Glucose Monitoring) - | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Vildagliptin

DRUG

Sitagliptin

Trial Locations (7)

Investigative Site, Bondy

Investigative Site, Corbeil

Investigative Site, Marseille

Investigative Site, Nancy

Investigative Site, Paris

Investigative Site, Toulouse

Investigative Site, Vénissieux